PRGX Announces Appointment of New Chief Financial Officer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
106
PRGX Announces Appointment of New Chief Financial Officer

ATLANTA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq: PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced that the Board of Directors has appointed Kurt Abkemeier as Chief Financial Officer, Treasurer and Controller, effective January 3, 2019. Peter Limeri, who has been serving as the interim Chief Financial Officer, Treasurer and Controller, will remain with the Company until the end of the month. 

“I would like to thank Pete for stepping into the interim role and assisting us during our search for a new CFO.  We wish him the very best,” said Ron Stewart, President and Chief Executive Officer.

“I am excited to welcome Kurt to the PRGX executive team. His financial expertise and experience in numerous software and technology companies will serve PRGX and our stakeholders well as we continue on our growth trajectory,” concluded Stewart.

Mr. Abkemeier joins PRGX from Fidelis Cybersecurity, Inc., a private equity-owned global cybersecurity software and cloud-based service provider, where he served as Chief Financial Officer.  Prior to Fidelis, Mr. Abkemeier served as Chief Financial Officer for Progress Software, Inc., a publicly traded global enterprise software company.  Mr. Abkemeier previously held senior finance roles at a number of other publicly traded companies, including Inteliquent, Inc., where he was Chief Financial Officer, Cbeyond, Inc. and Airgate PCS, Inc.  Mr. Abkemeier started his career at JP Morgan, a leading global investment bank.

In connection with Mr. Abkemeier’s employment and consistent with the terms of his employment agreement, the Company expects to grant equity awards today to Mr. Abkemeier consisting of 32,000 shares of restricted stock, 12,000 performance-based restricted stock units (PBUs), and options to purchase 100,000 shares of the Company's common stock. The restricted stock and options will vest in equal one-third increments on each of January 3, 2020, January 3, 2021 and January 3, 2022, subject to Mr. Abkemeier’s continued employment with the Company.  The options will have an exercise price equal to today’s closing price of the Company’s common stock on Nasdaq. The PBUs will have terms consistent with the terms of the PBUs granted to the Company’s executive officers on May 29, 2018 and will vest and become payable based on cumulative revenue from continuing operations, cumulative revenue from adjacent services and cumulative adjusted EBITDA from continuing operations that the Company achieves for the two-year performance period ending December 31, 2019.  Additionally, in connection with his employment and consistent with the terms of his employment agreement, the Company expects to grant an additional equity award to Mr. Abkemeier consisting of 24,000 PBUs, which is to be granted at the same time and on terms consistent with the terms of PBUs expected to be granted to the Company’s other executive officer direct reports of the Chief Executive Officer later this year.   In the event of a change in control of the Company, the restricted stock and options will vest in full and the PBUs will vest at the target level of financial performance, provided Mr. Abkemeier remains continuously employed by the Company until such event.

The grants were approved by the Compensation Committee of the Company's Board of Directors, which committee is comprised solely of independent directors, and were granted as an inducement material to Mr. Abkemeier entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

About PRGX PRGX Global, Inc. is a global leader in Recovery Audit and Spend Analytics services.  With over 1,500 employees, the Company serves clients in more than 30 countries and provides its services to 75% of the top 20 global retailers and over 25% of the top 50 companies in the Fortune 500. PRGX delivers more than $1 billion in cash flow improvement for its clients each year.  The creator of the recovery audit industry more than 40 years ago, PRGX continues to innovate through technology and expanded service offerings.  In addition to Recovery Audit, the Company provides Contract Compliance, Spend Analytics and Supplier Information Management services to improve clients’ financial performance and manage risk. For additional information on PRGX, please visit www.prgx.com .

Forward-Looking Statements In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company's overall condition and growth prospects and the Company’s execution of its business strategy. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company's future performance include revenue that does not meet expectations or justify costs incurred, the Company's ability to develop material sources of new revenue in addition to revenue from its core recovery audit services, changes in the market for the Company's services, the Company's ability to retain and attract qualified personnel, the Company's ability to integrate recent and future acquisitions, uncertainty in the credit markets, the Company's ability to maintain compliance with its financial covenants, client bankruptcies, loss of major clients, and other risks generally applicable to the Company's business. For a discussion of other risk factors that may impact the Company's business, please see the Company's filings with the Securities and Exchange Commission. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

PRGX Global, Inc. Ron Stewart, President & CEO 770.779.3900 600 Galleria Parkway, Suite 100 Atlanta, GA 30339

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 94

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 111

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 105

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Surgery Partners Deal Faces Fresh Price Scrutiny Ahead

Updated Category News Views 66

A $23.50 cash offer can look wonderfully tidy until somebody asks how the number was built. That is where Surgery Partners shareholders find themselves after Halper Sadeh LLC said it is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners. The firm is examining whether the company’s board obtained a fair price, ran a conflict-free process,...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 23

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print

Updated Category News Views 50

Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 65

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 47

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Deere & Co's Future Amid Repair Debates and Financial Insights

Updated Category News Views 81

Barclays Reconfirms Target for Deere & Co Barclays recently reaffirmed its Overweight rating on Deere & Co (NYSE: DE) and maintained a $400 price target, amidst an ongoing dialogue surrounding the right to repair. This discussion has re-emerged in the spotlight, temporarily impacting Deere's share price before it regained ground. The analyst noted that this issue has been...

Continue Reading
Inventor Offers Hospital Sign to Prevent Infections

Updated Category News Views 38

A Fresh Take on Infection Control Some days you stumble across an idea that just clicks—like the latest gadget for hospitals. Forget complex systems or high-tech cameras; this is about a simple sign that screams 'stop!' before you walk into trouble. It’s designed to safeguard hospital staff by alerting them to take precautions before entering rooms with infectious...

Continue Reading
JPMorgan Adjusts NOV Stock Outlook Amidst Market Challenges

Updated Category News Views 64

JPMorgan Adjusts NOV Stock Outlook Recently, JPMorgan made changes to its financial outlook for NOV Inc. (NYSE: NOV), a key player in the energy equipment and services sector. The investment firm lowered its price target from $23 to $22 but maintained an Overweight rating on the stock. This adjustment was driven by expectations of a slowdown in North American operations...

Continue Reading
Madrigal Pharmaceuticals Expands Workforce with Incentive Awards

Updated Category News Views 234

Madrigal Pharmaceuticals Strengthens Workforce with New Grants Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a leading biopharmaceutical company dedicated to innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH), has recently taken a significant step to bolster its team. The company announced granting equity inducement awards to 76 new...

Continue Reading
Pomerantz Investigates Investor Claims Against Abacus Global Management

Updated Category News Views 272

Pomerantz Law Firm's Investigation into Abacus Global Management In recent news, the Pomerantz Law Firm has embarked on an investigation regarding Abacus Global Management, Inc. (NASDAQ: ABL). This investigation revolves around potential securities fraud and other unlawful business practices committed by the company and some of its executive members. For investors...

Continue Reading